pyrotinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (1)
Unknown (1)

Interventional (1)
Observational (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Shanghai Jiao Tong University School of Medicine (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadbreast cancer

I am/have/hadher2+ breast cancer

I am/have/hadprogesterone

I am/have/hadplatelet count

I am/have/hadabsolute neutrophil count

I am/have/hadmetastasis

I am/have/hadgene amplification

I am/have/hadejection fraction

I am/have/hadinvasive breast cancer

I am/have/hadliver metastasis

I am/have/hadprogesterone receptor

I am/have/hadbreast cancer stage

I am/have/hadher2 gene amplification

I am/have/hadestrogen receptor

I am/have/hadestrogen

I am/have/hadadjuvant therapy

I am/have/hadimmunohistochemistry

I am/have/had12 lead electrocardiogram

I am/have/hadprimary tumor

I am/have/haderbb2 gene amplification

added new label for I am/have/had

more

I am looking for

I am looking forpyrotinib

I am looking fortrastuzumab

I am looking forher-2

I am looking forprogesterone

I am looking forestrogen

I am looking forpertuzumab

I am looking foremtansine

I am looking forerbb2

I am looking forpaclitaxel

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Pyrotinib Trastuzumab Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

This study aims to evaluate the efficacy and safety of pyrotinib in combination with trastuzumab, pertuzumab and nab-paclitaxel as neoadjuvant therapy in early stage or locally advanced HER2-positive breast cancer.

primary tumor

emtansine

gene amplification

breast cancer staging

adjuvant therapy

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Family Medicine
Recruiting

A Clinical Study of Pyrotinib in Patients of Advanced Colorectal Cancer With Her2 Variation

To Observe the Efficacy and Safety of Pyrotinib Maleate in Patients With Advanced HER2 Variation Colorectal Cancer

her-2

colorectal cancer

trastuzumab

liver metastasis

absolute neutrophil count

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.